AI tool to detect emotional state in cancer patients
Part of Cancer clinical trials.
This trial uses artificial intelligence to understand how cancer patients are feeling emotionally, which could help doctors provide better support. Participants will answer some questionnaires and have their responses analyzed by AI.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have been diagnosed with a tumor (confirmed by MRI or contrast-enhanced ultrasound).
- You must be able to understand and cooperate with the study.
- You must be willing to fill out psychological assessment questionnaires.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses an artificial intelligence model to predict how well breast cancer responds to neoadjuvant therapy (treatment before surgery). It aims to improve treatment planning by analyzing MRI scans taken before and after therapy.
This study is testing an interactive AI-based service to support the mental health of people with cancer. It is designed to help during or after cancer treatment.
This trial tests a non-invasive, AI-based monitoring program for people with solid tumors. It aims to help track how you’re doing during or after curative-intent treatment, using information collected without extra procedures.
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
This trial uses artificial intelligence to predict if a cancer might spread to other parts of the body. It may help doctors catch metastasis earlier and improve treatment planning.
This study tests a new computer-based education module created by artificial intelligence to help breast cancer patients understand their diagnosis and treatment options. The goal is to see if this tool helps patients feel more informed and prepared for their care.
Hear when a new Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.